Boehringer Ingelheim Advisory Panel on Retinal Imaging

Activity: Consultancy typesWork on advisory panel to industry or government or non-government organisation

Description

use of retinal imaging for determination of novel drug response
Period31 Aug 2017
Work forBoehringer Ingelheim International GmbH, Germany, Rhineland-Palatinate
Degree of RecognitionInternational